| Financial Year |
March 31 2023 |
| Monetary Funds |
644,398,087.30 |
| Held-for-trading Financial Assets |
1,000,000.00 |
| Notes Receivable |
105,508,259.95 |
| Accounts Receivable |
261,053,203.14 |
| Advances to Suppliers |
17,764,985.71 |
| Other Receivables |
41,794,527.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,243,244,848.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,004,735.14 |
| Total Current Assets |
2,407,346,604.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,094,890.36 |
| Investment Properties |
74,152,693.92 |
| Fixed Assetes |
2,057,075,410.94 |
| Under-construction Projects |
285,937,209.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,590,477.35 |
| R&D expenses |
-- |
| Goodwill |
26,255,602.40 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
228,728,242.06 |
| Other Non-Current Assets |
5,925,470.60 |
| Sub-Total of Non-Current Assets |
3,018,669,602.25 |
| Total Assets |
5,426,016,207.17 |
| Short-Term Loans |
319,531,551.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,321,304.69 |
| Accounts Payable |
482,136,855.77 |
| Accounts Received In Advance |
12,279,820.69 |
| Employee Compensation Payable |
38,363,025.50 |
| Taxes Payable |
29,982,503.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,395,977.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,190,712.98 |
| Other Current Liabilities |
112,616,016.80 |
| Sub-Total of Current Liabilities |
1,355,517,309.95 |
| Long-term Loans |
1,151,944,565.91 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,416,197.06 |
| Other Non-Current Liabilities |
385,466,666.67 |
| Sub-Total of Non-Current Liabilities |
1,723,065,539.12 |
| Total Liabilities |
3,078,582,849.07 |
| Paid-In Capital(Or Share Stock) |
800,245,171.00 |
| Capital Surplus |
2,557,504,810.46 |
| Surplus Reserve |
71,273,889.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,139,108,710.73 |
| Minority Stockholder's Interest |
958,704.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,346,474,653.85 |
| Owner's Equity（Stockholder's Equity） |
2,347,433,358.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,426,016,207.17 |
